Changes

'''{{FULLPAGENAME}}''' is member of the 2018 Guideline Development Group (GDG) of the [[WHO]]. The GDG's task is to develop updated recommendations on safe male circumcision for [[HIV ]] prevention and related service delivery for adolescent boys and men in generalized [[HIV ]] epidemics.<ref>{{REFweb

Nelly Mugo has a joint appointment at the Kenya Medical Research Institute (KEMRI) and the University of Washington (USA), department of global health. She heads the sexual reproductive adolescent child health research program, KEMRI. Her research focuses on both [[HIV ]] and cervical cancer prevention.

She leads a clinical trial site in Thika, Kenya that has conducted high impact [[HIV ]] prevention research including the Partners PrEP Study, the landmark clinical trial of pre-exposure prophylaxis (PrEP) for [[HIV ]] prevention among serodiscordant couples and the demonstration project of integrated PrEP and antiretroviral treatment for serodiscordant couples. This work has laid the foundation for PrEP implementation in Kenya and globally. She is the lead investigator for the Partners Scale up project, Thika site, and will be conducting a clinical trial on [[HIV ]] self-testing to reduce frequency of clinic visits for oral PrEP users.

She participated in the development of the Kenya [[HIV ]] Prevention Revolution Road Map and led the writing of the [[HIV ]] PrEP section of the Kenya 2016 ART guidelines. Dr. Mugo is currently a member of the Kenya PrEP technical working group and the reproductive cancer technical working group.

Dr. Mugo co-chaired the WHO Guidelines Committee for Couples [[HIV ]] Testing and Counseling and Antiretroviral Therapy for Treatment and Prevention in Serodiscordant Couples in 2011, the 2012 World Health Organization and Stakeholders’ Technical Consultation on Hormonal Contraception and [[HIV]], the WHO Guidelines Advisory Committee for PrEP for Prevention in 2015. She has been a member of the International Partnership for Microbicides (IPM), Safety Evaluation Committee Meeting providing oversight for the Ring study. She is well published and has presented in multiple global forum on the topic of [[HIV ]] prevention.<ref>{{REFdocument

PubMed lists Dr. Mugo as a named author of 108 papers on various subjects. A number of the papers relate to [[HIV ]] infection, especially in woman and as partners of [[HIV]]+ males. There is no clear indication of her position on male circumcision.